NCT00395694View on ClinicalTrials.gov

Clinical Evaluation of BW430C in Epilepsy

PHASE3CompletedINTERVENTIONAL
Enrollment

102

Participants

Timeline

Start Date

August 7, 2006

Primary Completion Date

March 1, 2009

Study Completion Date

March 26, 2009

Conditions
Epilepsy
Interventions
DRUG

lamictal

anti-epileptic drug

Trial Locations (2)

860-8556

GSK Investigational Site, Kumamoto

Unknown

GSK Investigational Site

Sponsors

Lead Sponsor

GlaxoSmithKline
All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY